Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
−Removed: Our common shares trade on the Nasdaq Global Select Market under the symbol “ABUS” following our name change to Arbutus Biopharma Corporation on July 31, 2015.
−Removed: As of February 28, 2023, there were 103 registered holders of common shares and 162,570,989 common shares issued and outstanding.
+Added: Our common shares trade on the Nasdaq Global Select Market under the symbol “ABUS”.
+Added: As of March 1, 2024, there were 102 registered holders of common shares and 179,492,199 common shares issued and outstanding.
Securities Authorized for Issuance under Equity Compensation Plans
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.